BioVie Inc. Payments of Stock Issuance Costs
BioVie Inc. (BIVI) reported Payments of Stock Issuance Costs of $368.37 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-08-16
- BioVie Inc. payments of stock issuance costs for the quarter ending 2022-09-30 was $368.37K, a 83.26% decline year-over-year.
- BioVie Inc. payments of stock issuance costs for the quarter ending 2021-09-30 was $2.20M.
- BioVie Inc. payments of stock issuance costs for fiscal 2022 was $2.22M, a 6.19% decline from fiscal 2021.
- BioVie Inc. payments of stock issuance costs for fiscal 2021 was $2.37M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 3 month as first filed | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|
| 2022-09-30 | $368.37K 10-Q · filed 2022-11-04 | ||
| 2022-06-30 | $2.22M 10-K · filed 2022-09-27 | ||
| 2021-09-30 | $2.20M 10-K · filed 2023-08-16 | $2.22M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $2.37M 10-K · filed 2022-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |